Press Releases
Jun 23, 2022
SIGA Announces $13 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat)
Jun 22, 2022
SIGA to Participate in Alliance Global Partners’ Monkeypox Panel on Thursday, June 23rd 2022
May 19, 2022
SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX® (tecovirimat)
May 12, 2022
New Contract Awarded by U.S. Department of Defense for the Procurement of up to Approximately $7.5 Million of Oral TPOXX®
May 05, 2022
SIGA Declares Special Dividend of $0.45 Per Share
Apr 28, 2022
SIGA Technologies to Host Business Update Call on May 5th, 2022 Following Release of First Quarter 2022 Financial Results
Mar 02, 2022
SIGA Announces Start of TPOXX® Post-Exposure Prophylactic (“PEP”) Clinical Trials
Feb 24, 2022
SIGA Technologies to Host Business Update Call on March 3rd, 2022 Following Release of Fourth Quarter and Full Year 2021 Financial Results
Jan 25, 2022
SIGA Announces Preclinical Oncology Research Collaboration with Bioarchitech
Jan 18, 2022
SIGA Technologies to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference from January 25-27th, 2022
Displaying 1 - 10 of 11